Mikhail D. Smirnov

584 total citations
16 papers, 494 citations indexed

About

Mikhail D. Smirnov is a scholar working on Hematology, Cell Biology and Nutrition and Dietetics. According to data from OpenAlex, Mikhail D. Smirnov has authored 16 papers receiving a total of 494 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Hematology, 5 papers in Cell Biology and 4 papers in Nutrition and Dietetics. Recurrent topics in Mikhail D. Smirnov's work include Blood Coagulation and Thrombosis Mechanisms (10 papers), Biotin and Related Studies (5 papers) and Vitamin K Research Studies (4 papers). Mikhail D. Smirnov is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (10 papers), Biotin and Related Studies (5 papers) and Vitamin K Research Studies (4 papers). Mikhail D. Smirnov collaborates with scholars based in United States, Russia and France. Mikhail D. Smirnov's co-authors include Charles T. Esmon, Naomi L. Esmon, Omid Safa, Pierre F. Neuenschwander, Patricia C. Liaw, Vladimir R. Muzykantov, Alexander L. Klibanov, Arthur E. Johnson, Subramanian Yegneswaran and Gennady P. Samokhin and has published in prestigious journals such as Journal of Biological Chemistry, Blood and FEBS Letters.

In The Last Decade

Mikhail D. Smirnov

15 papers receiving 484 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mikhail D. Smirnov United States 11 333 101 83 81 77 16 494
Jevgenia Zilberman‐Rudenko United States 13 206 0.6× 56 0.6× 97 1.2× 84 1.0× 107 1.4× 27 499
Veronika Rayzman Australia 5 159 0.5× 32 0.3× 186 2.2× 65 0.8× 77 1.0× 7 413
Hymie L. Nossel United States 14 292 0.9× 86 0.9× 68 0.8× 109 1.3× 76 1.0× 22 658
Kjell A. Grøttum Norway 12 257 0.8× 19 0.2× 41 0.5× 44 0.5× 90 1.2× 21 541
AJ Kleiss United States 7 785 2.4× 188 1.9× 222 2.7× 143 1.8× 53 0.7× 7 891
M.P.M. De Maat Netherlands 11 202 0.6× 72 0.7× 32 0.4× 96 1.2× 42 0.5× 16 430
Shiva Keshava United States 16 261 0.8× 43 0.4× 111 1.3× 32 0.4× 188 2.4× 33 584
Wenche Jy United States 9 207 0.6× 48 0.5× 31 0.4× 68 0.8× 171 2.2× 11 466
Johanna P. van Geffen Netherlands 14 221 0.7× 60 0.6× 42 0.5× 119 1.5× 67 0.9× 17 394
M. Jeremic Norway 12 270 0.8× 18 0.2× 67 0.8× 38 0.5× 44 0.6× 23 449

Countries citing papers authored by Mikhail D. Smirnov

Since Specialization
Citations

This map shows the geographic impact of Mikhail D. Smirnov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mikhail D. Smirnov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mikhail D. Smirnov more than expected).

Fields of papers citing papers by Mikhail D. Smirnov

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mikhail D. Smirnov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mikhail D. Smirnov. The network helps show where Mikhail D. Smirnov may publish in the future.

Co-authorship network of co-authors of Mikhail D. Smirnov

This figure shows the co-authorship network connecting the top 25 collaborators of Mikhail D. Smirnov. A scholar is included among the top collaborators of Mikhail D. Smirnov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mikhail D. Smirnov. Mikhail D. Smirnov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Toulon, Pierre, Mikhail D. Smirnov, Mark Triscott, et al.. (2009). A new chromogenic assay (HemosIL ThromboPath) is sensitive to major prothrombotic risk factors affecting the protein C pathway. Results of a multicenter study. Thrombosis Research. 124(1). 137–143. 27 indexed citations
2.
Toulon, Pierre, Mikhail D. Smirnov, Mark Triscott, & Armando Tripodi. (2007). A New Chromogenic Assay (HemosIL ThromboPath) Is Sensitive to Major Prothrombotic Risk Factors Affecting the Protein C Pathway. Results of a Multicenter Study.. Blood. 110(11). 1626–1626.
3.
Safa, Omid, Kenneth Hensley, Mikhail D. Smirnov, Charles T. Esmon, & Naomi L. Esmon. (2001). Lipid Oxidation Enhances the Function of Activated Protein C. Journal of Biological Chemistry. 276(3). 1829–1836. 20 indexed citations
4.
Esmon, Naomi L., Omid Safa, Mikhail D. Smirnov, & Charles T. Esmon. (2000). Antiphospholipid Antibodies and the Protein C Pathway. Journal of Autoimmunity. 15(2). 221–225. 51 indexed citations
5.
Liaw, Patricia C., Pierre F. Neuenschwander, Mikhail D. Smirnov, & Charles T. Esmon. (2000). Mechanisms by Which Soluble Endothelial Cell Protein C Receptor Modulates Protein C and Activated Protein C Function. Journal of Biological Chemistry. 275(8). 5447–5452. 142 indexed citations
6.
Yegneswaran, Subramanian, Mikhail D. Smirnov, Omid Safa, et al.. (1999). Relocating the Active Site of Activated Protein C Eliminates the Need for Its Protein S Cofactor. Journal of Biological Chemistry. 274(9). 5462–5468. 44 indexed citations
7.
Smirnov, Mikhail D., Omid Safa, Naomi L. Esmon, & Charles T. Esmon. (1999). Inhibition of Activated Protein C Anticoagulant Activity by Prothrombin. Blood. 94(11). 3839–3846. 58 indexed citations
8.
Smirnov, Mikhail D., Omid Safa, Naomi L. Esmon, & Charles T. Esmon. (1999). Inhibition of Activated Protein C Anticoagulant Activity by Prothrombin. Blood. 94(11). 3839–3846. 3 indexed citations
9.
Smirnov, Mikhail D., Omid Safa, Lisa M. Regan, et al.. (1998). A Chimeric Protein C Containing the Prothrombin Gla Domain Exhibits Increased Anticoagulant Activity and Altered Phospholipid Specificity. Journal of Biological Chemistry. 273(15). 9031–9040. 45 indexed citations
10.
Esmon, Naomi L., Mikhail D. Smirnov, & Charles T. Esmon. (1997). Thrombogenic Mechanisms of Antiphospholipid Antibodies. Thrombosis and Haemostasis. 78(1). 79–82. 29 indexed citations
11.
Smirnov, Mikhail D., et al.. (1995). Experimentally Targeted Thrombolytic Therapy. Annals of the New York Academy of Sciences. 750(1). 496–501. 3 indexed citations
12.
Smirnov, Mikhail D., et al.. (1993). Avidin attachment to biotinylated human neutrophils induces generation of superoxide anion. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1177(3). 229–235. 4 indexed citations
13.
Muzykantov, Vladimir R., Mikhail D. Smirnov, & Alexander L. Klibanov. (1993). Avidin attachment to red blood cells via a phoshpolipid derivative of biotin provides complement-resistant immunoerythrocytes. Journal of Immunological Methods. 158(2). 183–190. 28 indexed citations
14.
Muzykantov, Vladimir R., Mikhail D. Smirnov, & Alexander L. Klibanov. (1993). Avidin attachment to biotinylated amino groups of the erythrocyte membrane eliminates homologous restriction of both classical and alternative pathways of the complement. FEBS Letters. 318(2). 108–112. 19 indexed citations
15.
Muzykantov, Vladimir R., et al.. (1993). Interaction of avidin-carrying red blood cells with nucleated cells. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1179(2). 148–156. 3 indexed citations
16.
Smirnov, Mikhail D., et al.. (1992). Avidin-induced lysis of biotinylated erythrocytes by homologous complement via the alternative pathway depends on avidin's ability of multipoint binding with biotinylated membrane. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1107(1). 119–125. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026